[go: up one dir, main page]

MX2018016411A - Resinas de cannabis descarboxiladas, usos de las mismas y metodos para elaborarlas. - Google Patents

Resinas de cannabis descarboxiladas, usos de las mismas y metodos para elaborarlas.

Info

Publication number
MX2018016411A
MX2018016411A MX2018016411A MX2018016411A MX2018016411A MX 2018016411 A MX2018016411 A MX 2018016411A MX 2018016411 A MX2018016411 A MX 2018016411A MX 2018016411 A MX2018016411 A MX 2018016411A MX 2018016411 A MX2018016411 A MX 2018016411A
Authority
MX
Mexico
Prior art keywords
cannabis
methods
decarboxiladas
reserves
prepare
Prior art date
Application number
MX2018016411A
Other languages
English (en)
Inventor
Maureen LEWIS Melissa
WASILEWSKI Ewa
Grover Har
Premakanth KOTRA Lakshmi
Original Assignee
Cannscience Innovations Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cannscience Innovations Inc filed Critical Cannscience Innovations Inc
Publication of MX2018016411A publication Critical patent/MX2018016411A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/02—Solvent extraction of solids
    • B01D11/0211—Solvent extraction of solids in combination with an electric or magnetic field
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/775—Phenolic resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/02—Solvent extraction of solids
    • B01D11/0261—Solvent extraction of solids comprising vibrating mechanisms, e.g. mechanical, acoustical
    • B01D11/0265—Applying ultrasound
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/02—Solvent extraction of solids
    • B01D11/0288—Applications, solvents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Acoustics & Sound (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La descripción se refiere a resinas de cannabis descarboxiladas y métodos para hacer las resinas de cannabis descarboxiladas mediante la extracción y descarboxilación de cannabinoides de la especie Cannabis utilizando microondas y solventes. La descripción también se refiere al uso de las resinas de cannabis descarboxiladas para hacer productos farmacéuticos que comprenden las mismas.
MX2018016411A 2016-06-29 2017-06-29 Resinas de cannabis descarboxiladas, usos de las mismas y metodos para elaborarlas. MX2018016411A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662356262P 2016-06-29 2016-06-29
PCT/CA2017/050788 WO2018000094A1 (en) 2016-06-29 2017-06-29 Decarboxylated cannabis resins, uses thereof and methods of making same

Publications (1)

Publication Number Publication Date
MX2018016411A true MX2018016411A (es) 2019-05-09

Family

ID=60785699

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018016411A MX2018016411A (es) 2016-06-29 2017-06-29 Resinas de cannabis descarboxiladas, usos de las mismas y metodos para elaborarlas.

Country Status (8)

Country Link
US (3) US10143706B2 (es)
EP (1) EP3478307A4 (es)
JP (1) JP2019524655A (es)
CN (1) CN109475586A (es)
AU (1) AU2017290107A1 (es)
CA (1) CA3010636A1 (es)
MX (1) MX2018016411A (es)
WO (1) WO2018000094A1 (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX380274B (es) 2011-06-30 2025-03-12 Gallo Winery E & J Colorante cristalino natural y proceso para producción.
JP6377126B2 (ja) 2013-03-15 2018-08-22 イー アンド ジェイ ガロ ワイナリー 調節可能な空調空気流を用いた乾燥機
JP2019524655A (ja) 2016-06-29 2019-09-05 キャンサイエンス イノベーションズ インコーポレーテッドＣａｎｎｓｃｉｅｎｃｅ Ｉｎｎｏｖａｔｉｏｎｓ Ｉｎｃ． 脱炭酸大麻樹脂、その使用、及びそれを製造する方法
BR112019011342A2 (pt) * 2016-12-01 2019-10-15 Natural Extraction Systems, LLC dispositivo de destilação de óleo botânico rápido que utiliza agente de micro-ondas
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10807098B1 (en) 2017-07-26 2020-10-20 Pearson Incorporated Systems and methods for step grinding
US10611641B2 (en) * 2017-10-07 2020-04-07 Dakota Zachariah Ferry Hemp-derived dicarboxylic acid-functionalized graphene
PE20210251A1 (es) 2017-10-30 2021-02-09 Whistler Tech Corp Metodos y sistemas de enriquecimiento de terpenos
WO2019119153A1 (en) * 2017-12-22 2019-06-27 CannScience Innovations Inc. Apparatus and method for extraction and decarboxylation of phytocannabinoids
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder
WO2019207554A1 (en) * 2018-04-27 2019-10-31 Radient Technologies Inc. Extraction of compounds from cannabis biomass using food-grade solvent
WO2019211794A1 (en) * 2018-05-03 2019-11-07 Radient Technologies Inc. Extraction using a microwave assisted extractor
WO2019211795A1 (en) * 2018-05-03 2019-11-07 Radient Technologies Inc. Continuous flow microwave-assisted extraction of a cannabis biomass
WO2019211768A1 (en) * 2018-05-03 2019-11-07 Radient Technologies Inc. Obtaining cannabis extracts from biomass for use in food
WO2019211797A1 (en) * 2018-05-03 2019-11-07 Radient Technologies Inc. Method of decarboxylating acidic cannabinoids in cannabis extract suspended within a carrier fluid
US10695316B2 (en) * 2018-07-03 2020-06-30 Virgil Macaluso Methods of heating cannabis plant material
WO2020028198A1 (en) 2018-08-03 2020-02-06 Biomass Oil Separation Solutions, Llc Processes and apparatus for extraction of substances and enriched extracts from plant material
US10669248B2 (en) 2018-08-10 2020-06-02 Natural Extraction Systems, LLC Methods to chemically modify cannabinoids
US10822320B2 (en) 2018-08-10 2020-11-03 Natural Extraction Systems, LLC Methods to purify cannabinoids
US12420214B2 (en) 2018-08-10 2025-09-23 Natural Extraction Systems, LLC Methods to produce products comprising cannabinoids
US10570350B1 (en) 2018-08-17 2020-02-25 Evello International, LLC Systems and methods of cannabis oil extraction
US10688410B2 (en) 2018-08-17 2020-06-23 Evello International, LLC Systems and methods of cannabis oil extraction
EP3864000A4 (en) 2018-10-10 2022-08-10 Treehouse Biosciences, Inc. CANNABIGEROL SYNTHESIS
WO2020084371A1 (en) * 2018-10-23 2020-04-30 Radient Technologies Innovations Inc. Extracting active compounds from a biomass
US10751722B1 (en) 2018-10-24 2020-08-25 Pearson Incorporated System for processing cannabis crop materials
US11221179B2 (en) 2018-10-26 2022-01-11 E. & J. Gallo Winery Low profile design air tunnel system and method for providing uniform air flow in a refractance window dryer
US10785906B2 (en) 2019-02-19 2020-09-29 Pearson Incorporated Plant processing system
WO2020176547A1 (en) 2019-02-25 2020-09-03 Ginkgo Bioworks, Inc. Biosynthesis of cannabinoids and cannabinoid precursors
WO2020219687A1 (en) 2019-04-23 2020-10-29 Joint Venture Holdings, LLC Cannabis processing systems and methods
CN111848364B (zh) * 2019-04-30 2021-04-02 云南汉盟制药有限公司 从大麻中提取大麻二酚的方法
WO2020232193A1 (en) * 2019-05-16 2020-11-19 S.S. Steiner, Inc. Microwave-assisted decarboxylation of organic acids in hemp materials
CN110041171A (zh) * 2019-05-31 2019-07-23 黑龙江阳光工业大麻研究院 一种从工业大麻叶子中提取大麻二酚的方法
KR102256712B1 (ko) * 2019-06-05 2021-05-28 한국과학기술연구원 칸나비스 식물로부터 칸나비디올을 분리하는 방법 및 그 용도
CN110218610A (zh) * 2019-06-06 2019-09-10 昆明萃醍生物科技有限公司 一种从工业大麻干花叶中提取cbd油的方法
KR102287355B1 (ko) * 2019-07-01 2021-08-06 한국과학기술연구원 칸나비스 식물로부터 테트라히드로칸나비놀을 분리하는 방법 및 그 용도
US10799546B1 (en) 2019-07-26 2020-10-13 Biomass Oil Separation Solutions, Llc Modular, integrated process and apparatus for extracting, refining and remediating active substances from plant material
KR102277523B1 (ko) * 2019-10-04 2021-07-14 한국과학기술연구원 칸나비스 식물로부터 칸나비디올을 연속으로 제조하는 방법 및 그 용도
US11826673B2 (en) 2019-10-25 2023-11-28 Chimera Technology LLC Solvent-less extraction of cannabinoid acids
US11547954B2 (en) 2019-10-25 2023-01-10 Chimera Technology LLC. Compound extraction from plant based material utilizing terepene saturant
US10757860B1 (en) 2019-10-31 2020-09-01 Hemp Processing Solutions, LLC Stripper apparatus crop harvesting system
US10933424B1 (en) 2019-12-11 2021-03-02 Pearson Incorporated Grinding roll improvements
KR102311749B1 (ko) * 2019-12-31 2021-10-13 한국과학기술연구원 칸나비스 식물로부터 칸나비놀을 연속으로 제조하는 방법 및 그 용도
US11351476B2 (en) 2020-01-07 2022-06-07 Agrify Corporation Method for chemical separation of cannabinoids
WO2021142075A1 (en) * 2020-01-07 2021-07-15 Precision Extraction Corporation Microwave assisted decarboxylation of cannabis resins
CA3164725A1 (en) * 2020-01-24 2021-07-29 E.&J. Gallo Winery Systems and methods for processing cannabis plant materials
US10919828B1 (en) * 2020-02-14 2021-02-16 Aicardo Roa-Espinosa Process for manufacturing cannabidiol
WO2021236301A1 (en) * 2020-05-20 2021-11-25 MACH Technologies Alcohol solvent recovery and plant oil decarboxylation apparatus and method
US20220009866A1 (en) * 2020-06-23 2022-01-13 Antares Agriculture Group, LLC Systems and methods for extracting and isolating bio-oils and powders from biomass using hydraulic hammering
CN112266321A (zh) * 2020-10-15 2021-01-26 黑龙江省科学院大庆分院 一种工业大麻中大麻二酚酸脱羧制备大麻二酚的方法
KR102226394B1 (ko) * 2020-12-21 2021-03-11 강원대학교산학협력단 대마(헴프)에서 고농도 카나비디올(cbd) 화합물을 추출하는 가공기술
KR102465259B1 (ko) * 2021-01-18 2022-11-09 강원대학교산학협력단 대마 잎에서 항산화 물질 및 카나비노이드 증대를 위한 가공기술
CN113073009A (zh) * 2021-04-21 2021-07-06 云南康贝特生物科技有限公司 一种同时提取工业大麻芳香水和提高工业大麻原料cbd含量的前处理干燥方法
WO2022265911A1 (en) * 2021-06-18 2022-12-22 Lieberman Ori Crystalline resin containing microscopic surface reliefs and methods and systems for generating the same
GB202110543D0 (en) * 2021-07-22 2021-09-08 Nicoventures Trading Ltd Delivery system
EP4129435A3 (en) 2021-08-03 2023-05-24 THC LAB S.r.l. Method for extracting active ingredients from plant material
CN113567592B (zh) * 2021-08-25 2022-12-13 深圳波顿香料有限公司 快速检测电子烟液中大麻二酚的方法
US11911427B2 (en) 2022-03-12 2024-02-27 Wilhelm Rumpf Extraction and infusion of active components from plant materials
EP4493168A1 (en) * 2022-03-16 2025-01-22 Buzzelet Development And Technologies Ltd Cannabinoid-containing compositions
WO2023175125A1 (en) 2022-03-18 2023-09-21 Alkion Bioinnovations Biological method for decarboxylation of cannabinoids directly in plant tissues

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221778A (en) 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
US4279824A (en) 1979-11-01 1981-07-21 Mckinney Laurence O Method and apparatus for processing herbaceous plant materials including the plant cannabis
CA2122479C (en) 1991-11-22 1998-08-25 Richard John Dansereau Risedronate delayed-release compositions
US6061926A (en) 1997-11-05 2000-05-16 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of The Environment Controlled energy density microwave-assisted processes
US6730519B2 (en) 1998-10-26 2004-05-04 The University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6403126B1 (en) 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
CA2402020C (en) 2000-03-09 2006-08-29 Gw Pharma Limited Pharmaceutical compositions
CA2533400C (en) 2001-02-14 2017-01-03 Gw Pharma Limited Cannabinoids pharmaceutical formulations
GB2377633A (en) 2001-05-11 2003-01-22 Gw Pharmaceuticals Ltd Pharmaceutical compositions comprising the cannabinoids THC and CBD
US10004684B2 (en) 2001-02-14 2018-06-26 Gw Pharma Limited Pharmaceutical formulations
US7025992B2 (en) 2001-02-14 2006-04-11 Gw Pharma Limited Pharmaceutical formulations
GB2381194A (en) 2001-09-07 2003-04-30 Gw Pharmaceuticals Ltd Pharmaceutical formulations
JP4467883B2 (ja) 2001-02-14 2010-05-26 ジーダブリュー・ファーマ・リミテッド 医薬製剤
GB2377218A (en) * 2001-05-04 2003-01-08 Gw Pharmaceuticals Ltd Process and apparatus for extraction of active substances and enriched extracts from natural products
US20030008005A1 (en) 2001-07-05 2003-01-09 R.T. Alamo Ventures, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
JP2005526715A (ja) 2002-02-01 2005-09-08 レゾリューション ケミカルズ リミテッド Δ９−テトラヒドロカンナビノールの製造
UA79281C2 (en) 2002-04-03 2007-06-11 Solvay Pharm Bv Stabilized composition comprising a natural cannabinoid compound and process for the preparation thereof
CA2391454A1 (en) 2002-06-25 2003-12-25 Websar Innovations Inc. Cannabinoid extraction method
ES2377819T3 (es) 2002-08-14 2012-04-02 Gw Pharma Limited Formulaciones líquidas cannabinoides para administración mucosal
US7344736B2 (en) 2002-08-14 2008-03-18 Gw Pharma Limited Extraction of pharmaceutically active components from plant materials
GB2391865B (en) 2002-08-14 2005-06-01 Gw Pharma Ltd Improvements in the extraction of pharmaceutically active components from plant materials
CA2994322A1 (en) 2002-08-14 2004-02-14 Gw Pharma Limited Botanical drug substances comprising various proportions of thc and cbd
US6946150B2 (en) 2002-08-14 2005-09-20 Gw Pharma Limited Pharmaceutical formulation
GB2392093B (en) 2002-08-14 2006-03-08 Gw Pharma Ltd Pharmaceutical formulations
GB0222077D0 (en) 2002-09-23 2002-10-30 Gw Pharma Ltd Methods of preparing cannabinoids from plant material
GB2393182B (en) 2002-09-23 2007-03-14 Gw Pharma Ltd Method of preparing cannabidiol from plant material
GB2394894B (en) 2002-11-04 2005-08-31 G W Pharma Ltd New use for pharmaceutical composition
WO2004067004A1 (en) 2003-01-31 2004-08-12 Orexo Ab A rapid-acting pharmaceutical composition
US20060211752A1 (en) 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
CA2812925C (en) 2004-11-12 2015-07-21 North Carolina State University Methods and apparatuses for thermal treatment of foods and other biomaterials, and products obtained thereby
WO2006133733A1 (en) 2005-06-13 2006-12-21 Flamel Technologies Oral dosage form comprising an antimisuse system
GB2432312A (en) 2005-11-01 2007-05-23 Gw Pharma Ltd Pharmaceutical compositions for the treatment of pain
FR2892937B1 (fr) 2005-11-10 2013-04-05 Flamel Tech Sa Forme pharmaceutique orale microparticulaire anti-mesusage
US8652529B2 (en) 2005-11-10 2014-02-18 Flamel Technologies Anti-misuse microparticulate oral pharmaceutical form
GB2434312B (en) 2006-01-18 2011-06-29 Gw Pharma Ltd Cannabinoid-containing plant extracts as neuroprotective agents
FR2901478B1 (fr) 2006-05-24 2015-06-05 Flamel Tech Sa Forme pharmaceutique orale multimicroparticulaire a liberation prolongee
US9023400B2 (en) 2006-05-24 2015-05-05 Flamel Technologies Prolonged-release multimicroparticulate oral pharmaceutical form
GB2438682A (en) 2006-06-01 2007-12-05 Gw Pharma Ltd New use for cannabinoids
US8481085B2 (en) 2006-06-15 2013-07-09 Gw Pharma Limited Pharmaceutical compositions comprising cannabigerol
GB2439393B (en) 2006-06-23 2011-05-11 Gw Pharma Ltd Cannabinoids for use in the treatment of neuropathic pain
FR2904557B1 (fr) 2006-08-01 2010-04-30 Pf Medicament Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques
WO2008024408A2 (en) 2006-08-22 2008-02-28 Theraquest Biosciences, Inc. Pharmaceutical formulations of cannabinoids for application to the skin and method of use
WO2008024490A2 (en) 2006-08-24 2008-02-28 Theraquest Biosciences, Inc. Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use
WO2008027442A2 (en) 2006-08-30 2008-03-06 Theraquest Biosciences, Llc Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
GB2448535A (en) 2007-04-19 2008-10-22 Gw Pharma Ltd New use for cannabinoid-containing plant extracts
KR100895942B1 (ko) 2007-05-08 2009-05-07 조선대학교산학협력단 생약 추출물을 함유하는 구강 내 속붕해성 제제 조성물 및그의 제조 방법
GB2450493A (en) 2007-06-25 2008-12-31 Gw Pharma Ltd Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors
GB2450741A (en) 2007-07-05 2009-01-07 Gw Pharma Ltd Cannabinoid containing plant extracts in the treatment of inflammatory bowel disease
GB2450753B (en) 2007-07-06 2012-07-18 Gw Pharma Ltd New Pharmaceutical formulation
GB2451254A (en) 2007-07-24 2009-01-28 Gw Pharma Ltd Cannabidiol for use in the treatment of neurodegenerative conditions
EP2963031B1 (en) 2007-11-30 2019-02-06 Zynerba Pharmaceuticals, Inc. Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
GB2456183A (en) 2008-01-04 2009-07-08 Gw Pharma Ltd Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
GB2459125B (en) 2008-04-10 2013-01-02 Gw Pharma Ltd Method if extracting cannabichromene and its acid from Cannabis sativa plant material
WO2010150245A1 (en) 2009-06-24 2010-12-29 Tikun Olam Ltd. Pharmaceutical and cosmeceutical compositions containing cannabis flower and seed extracts
GB2471523A (en) 2009-07-03 2011-01-05 Gw Pharma Ltd Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
GB2479153B (en) 2010-03-30 2014-03-19 Gw Pharma Ltd The phytocannabinoid cannabidivarin (CBDV) for use in the treatment of epilepsy
TWI583374B (zh) 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
US20130224151A1 (en) 2010-03-31 2013-08-29 United States Of America Use of FAAH Inhibitors for Treating Abdominal, Visceral and Pelvic Pain
WO2011127933A1 (en) 2010-04-16 2011-10-20 Nuevolution A/S Bi-functional complexes and methods for making and using such complexes
US20120043242A1 (en) 2010-08-19 2012-02-23 Andrew David Hospodor Medicinal cannabis fatty foodstuff
WO2012030951A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Fast-dissolve dosage forms of 5-ht2c agonists
GB2487712B (en) 2011-01-04 2015-10-28 Otsuka Pharma Co Ltd Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
GB2491118B (en) 2011-05-20 2015-12-30 Otsuka Pharma Co Ltd Cannabinoids for use in the treatment of neuropathic pain
GB201111261D0 (en) 2011-07-01 2011-08-17 Gw Pharma Ltd Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
GB2495118B (en) 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
GB2496688B (en) 2011-11-21 2016-06-29 Gw Pharma Ltd Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases
CN102585999A (zh) * 2012-01-16 2012-07-18 河南中医学院 一种用于榨取火麻仁油的方法
IN2014DN09507A (es) 2012-05-03 2015-07-17 Echo Pharmaceuticals Bv
CN103446100A (zh) 2012-05-29 2013-12-18 鲁南制药集团股份有限公司 牛蒡子苷元的舌下含服制剂
GB2504263B (en) 2012-06-08 2015-09-16 Gw Pharma Ltd Synergistic therapies for neuroprotection
US20130334045A1 (en) 2012-06-14 2013-12-19 ChemiSensor LLP Distributable Chemical Sampling and Sensing System
CA2780578A1 (en) 2012-06-19 2013-12-19 Radient Technologies Inc. Method for direct extraction and concentration of naturally-derived active compounds
US9018246B2 (en) 2012-09-05 2015-04-28 Lp Pharmaceutical (Xiamen) Co., Ltd. Transmucosal administration of taxanes
EP4137142A1 (en) 2013-03-14 2023-02-22 Purple Mundo, Inc. Bioactive concentrates and uses thereof
GB2513167B (en) 2013-04-18 2016-03-02 Otsuka Pharma Co Ltd Tetrahydrocannabivarin for use in the treatment of nausea and vomiting
CA2931486A1 (en) 2013-11-05 2015-05-14 Ardent Llc Sublingual cannabis dosage form and methods of making and using the same
CA2930266A1 (en) 2013-11-11 2015-05-14 The Werc Shop, LLC Solvent-free processing, system and methods
CA2942867C (en) 2014-03-18 2022-08-30 Izun Pharmaceuticals Corp. Protein-bound cannabinoid compositions
US9186386B2 (en) 2014-04-17 2015-11-17 Gary J. Speier Pharmaceutical composition and method of manufacturing
US9044390B1 (en) 2014-04-17 2015-06-02 Gary J. Speier Pharmaceutical composition and method of manufacturing
WO2016004121A1 (en) 2014-07-01 2016-01-07 MJAR Holdings, LLC High cannabidiol cannabis strains
US9340475B2 (en) * 2014-07-02 2016-05-17 Cv Sciences, Inc. Process for generating hemp oil with a high cannabidiol (CBD) content
US11077086B2 (en) 2014-07-21 2021-08-03 Pharmaceutical Productions, Inc. Solid dosage form composition for buccal or sublingual administration of cannabinoids
US20160058866A1 (en) 2014-09-02 2016-03-03 Ronald D. Sekura Alternative solutions for the administration of cannabis derived botanical products
US20160143972A1 (en) 2014-11-21 2016-05-26 Cannamark Inc. Method and apparatus for preparing a solid form of cannabinoid
CA2968929A1 (en) 2014-11-26 2016-06-02 One World Cannabis Ltd Synergistic use of cannabis for treating multiple myeloma
WO2016092539A1 (en) 2014-12-07 2016-06-16 One World Cannabis Ltd Use of cannabis to treat migraine
CN104523958A (zh) 2014-12-18 2015-04-22 高红煜 复方西洋参舌下片及其制备方法
WO2016126592A1 (en) 2015-02-02 2016-08-11 Axim Biotechnologies, Inc. Cannabinoid and sugar alcohol complex, methods to make and use
CA2898513A1 (en) 2015-07-27 2017-01-27 Stephan HEATH Methods, products, and systems relating to making, providing, and using nanocrystalline (nc) products comprising nanocrystalline cellulose (ncc), nanocrystalline (nc) polymers and/or nanocrystalline (nc) plastics or other nanocrystals of cellulose composites or structures, in combination with other materials
US20180271827A1 (en) 2015-09-24 2018-09-27 Pasenture, Inc. Cannabinoid compositions and methods of making
BR112018068986B1 (pt) 2016-03-18 2023-03-21 Christopher Brian Reid Composição para reduzir a expressão oncógena de uma célula, tecido ou órgão de um indivíduo
JP2019524655A (ja) 2016-06-29 2019-09-05 キャンサイエンス イノベーションズ インコーポレーテッドＣａｎｎｓｃｉｅｎｃｅ Ｉｎｎｏｖａｔｉｏｎｓ Ｉｎｃ． 脱炭酸大麻樹脂、その使用、及びそれを製造する方法
IL246790A0 (en) 2016-07-14 2016-09-29 Friedman Doron Self-dissolving compounds of cannabinoids
AU2018216173A1 (en) 2017-02-05 2019-08-08 CannTab Therapeutics Limited Flash-melt cannabinoid formulations

Also Published As

Publication number Publication date
US10143706B2 (en) 2018-12-04
US20180000857A1 (en) 2018-01-04
CA3010636A1 (en) 2018-01-04
AU2017290107A1 (en) 2019-01-17
JP2019524655A (ja) 2019-09-05
EP3478307A4 (en) 2020-02-26
US20190038663A1 (en) 2019-02-07
US20190336521A1 (en) 2019-11-07
US10383892B2 (en) 2019-08-20
CN109475586A (zh) 2019-03-15
WO2018000094A1 (en) 2018-01-04
US10537592B2 (en) 2020-01-21
EP3478307A1 (en) 2019-05-08

Similar Documents

Publication Publication Date Title
MX2018016411A (es) Resinas de cannabis descarboxiladas, usos de las mismas y metodos para elaborarlas.
CO2018000648A2 (es) Compuestos de piridina sustituidos, intermediarios para su preparación y composiciones que los comprenden
CL2018001667A1 (es) 3-azabiciclo[3.1.0]hexanos sustituidos como inhibidores de cetohexoquinasa
CO2017011535A2 (es) Composiciones de ácido obeticólico y métodos de uso
MX390064B (es) Formas cristalinas de mononucleotido de beta-nicotinamida.
CR20180564A (es) Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que lo contienen
CL2016001127A1 (es) Cepas de penicillium antifúngicas, sus extrolitos fungicidas, y su uso.
EA201790880A1 (ru) Экстракты конопли и способы их получения и применения
CL2018000182A1 (es) Compuesto que se dirige a il-23a y al factor de activación de linfocitos b (baff) y usos de estos
AR103077A1 (es) Método para la producción de un sistema de administración farmacéutica
MX386158B (es) Derivados de 1,7-diaril-1,6-heptadien-3,5-diona, procedimiento para la preparación y uso de los mismos
UY35986A (es) Método mejorado para la producción de extractos de ginkgo
CL2018002811A1 (es) Derivados de aminotiazol útiles como agentes antivíricos.
AR105894A1 (es) Composición para aplicación tópica que comprende dimetil isosorbida, un poliol, y un antioxidante fenólico o polifenólico
BR112017024102A2 (pt) formulação bioestimulante para melhorar o crescimento de plantas e usos da mesma
UY36602A (es) Variantes de protoxina-ii y métodos de uso
MX2016012784A (es) Composiciones farmaceuticas solidas que comprenden derivados de biopterina y usos de tales composiciones.
CO2019003424A2 (es) Extracto de planta impregnado de alulosa y método de preparación para el mismo
BR112016025024A2 (pt) ?processo para preparar compostos ceto, e, uso de farnesil acetona?
MX2017002383A (es) Acidos ciclohexanocarboxilicos para enmascaramiento selectivo de sabor.
MX2019000862A (es) Recipiente de preparacion de alimentos de un solo uso montaje, sistema y metodo.
CO2019008110A2 (es) Activador de nrf2
AR109504A1 (es) Mermelada de fruta que comprende alulosa y método para preparar la misma
CL2015003798A1 (es) Composición natural antioxidante y antibacteriana, elaborada a partir de extractos fenolicos de aristotelia chilensis y procesos de obtención.
BR112017009465A2 (pt) processos para recuperar álcoois